Spring Co-Op 2027, Commercial Analytics
Vertex Pharmaceuticals
Summary
The Vertex Commercial Analytics Co-Op is a 6-month experiential training program for students currently working towards an advanced degree in Data Analytics, Business, Statistics or other related fields. If you are passionate, collaborative, and growth-minded, a co-op at Vertex will help you gain meaningful experience in our Commercial functional areas and serve as a launchpad for your career.
Job description
Your Impact
The Vertex Commercial Analytics Co-Op is a 6-month experiential training program for students currently working towards an advanced degree in Data Analytics, Business, Statistics or other related fields. If you are passionate, collaborative, and growth-minded, a co-op at Vertex will help you gain meaningful experience in our Commercial functional areas and serve as a launchpad for your career.
What you will be doing
The Commercial Analytics Intern will support the Commercial Analytics team in preparation for a rare disease launch. This project-oriented internship will provide educational exposure to commercial analytics work and opportunities to contribute to defined launch-related analyses, deliverables, and planning activities.
Key Responsibilities
- Support project-oriented commercial analytics assignments related to rare disease launch preparation.
- Assist with analysis, organization, and communication of commercial data and insights that support launch planning.
- Contribute to defined project deliverables and complete work in accordance with assigned timelines.
- Participate in interactions with relevant internal stakeholders to support project execution and alignment.
- Develop and present summaries of analyses, findings, and recommendations as appropriate.
- Potential assignments may include supporting launch-related market, customer, performance, or business analyses, depending on the team’s identified priorities.
Qualifications
- Currently pursuing a degree at the undergraduate or graduate level in Statistics, Data Analytics, Business or a related field.
- Demonstrated interest in commercial analytics and/or rare disease commercial work.
- Strong analytical, organizational, and communication skills.
- Ability to work on defined projects, manage deliverables, and meet assigned timelines.
- Legal authorization to work in the United States, now and in the future.
- Please note that Vertex does not provide sponsorship for internships/co-ops or entry level roles within this part of the organization.
- You must be enrolled in an advanced degree program if graduating before May 2027
- You must be available to work full-time, 40 hours per week from January – July 2027
Requirements
- Currently pursuing a degree at the undergraduate or graduate level in Statistics, Data Analytics, Business or a related field.
- Demonstrated interest in commercial analytics and/or rare disease commercial work.
- Strong analytical, organizational, and communication skills.
- Ability to work on defined projects, manage deliverables, and meet assigned timelines.
- Legal authorization to work in the United States, now and in the future.
- You must be enrolled in an advanced degree program if graduating before May 2027
- You must be available to work full-time, 40 hours per week from January – July 2027
Benefits
- Gym access
- Group exercise classes
- Subsidized commuter benefits
- Free breakfast
- Career development opportunities
- Social events
- Medical benefits
- Dental benefits
- Vision benefits
- Paid time off
- Educational assistance
- Student loan repayment
- Commuting subsidy
- Matching charitable donations
- 401(k)
Company overview
Vertex Pharmaceuticals is a global biotechnology company headquartered in Boston, Massachusetts, founded in 1989. The company specializes in discovering, developing, and commercializing transformative medicines for serious diseases, with a primary focus on cystic fibrosis (CF). Vertex has pioneered breakthrough therapies including TRIKAFTA/KAFTRIO, SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO, which collectively treat approximately 90% of CF patients. Beyond CF, the company has expanded its portfolio to include treatments for sickle cell disease, transfusion-dependent beta thalassemia, acute pain, and has robust clinical pipelines in APOL1-mediated kidney disease, type 1 diabetes, myotonic dystrophy type 1, and alpha-1 antitrypsin deficiency. Vertex employs approximately 6,100 people globally and maintains research facilities in San Diego, California, and Milton Park, Oxfordshire, England. The company is publicly traded on NASDAQ (VRTX) and is recognized as one of the industry's top workplaces, consistently earning accolades for its innovative culture and patient-focused approach to drug development.